Saturday 17 October 2026 Export NAGE’s income statement to Excel — free account

Niagen Bioscience, Inc.

Niagen Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.4 million, up 29.9% from fiscal 2024. In the quarter to June 2026, revenue fell 4.28%, EPS fell 80.0% and free cash flow grew 140.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

2.49 0.09 −3.49%

Follow NAGE

Alert me

Market cap: $204.2M
P/E: 12.5×
Fwd P/E: 15.0×
Dividend yield: —
F-score: 6/9
Altman Z: 10.54
Beneish M: −1.55
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	38.90%	28.35%	27.07%	21.80%
Piotroski F-Score Full definition →		7	6	5	5
ROA Full definition →		26.42%	19.90%	19.05%	16.14%
ROIC Full definition →		188.93%	86.63%	51.81%	41.95%
Return on Tangible Assets Full definition →		28.22%	22.22%	22.29%	19.04%
Average Days of Receivables Full definition →		24.90	27.47	36.57	24.26
Free Cash Flow per Share Full definition →		0.27	0.17	0.12	0.14
Free Cash Flow Full definition →		21.15	13.21	9.91	11.47
Capital Expenditures Full definition →		(0.26)	(0.29)	5.48	5.53
Other line items
Cash ROIC Full definition →		15.67%	9.35%	6.65%	7.69%
Accounts Receivable Turnover Full definition →		15.99	14.78	12.96	14.16
Accounts Payable Turnover Full definition →		4.58	4.79	3.90	3.99
Inventory Turnover Full definition →		3.07	3.12	2.65	2.63
Average Days of Payables Full definition →		103.29	85.23	104.03	74.63
Days of Inventory on Hand Full definition →		152.32	161.24	188.18	163.20
Tax Rate Full definition →		(0.02)	(0.04)	(0.05)	(0.06)
Research and Development Expense of Revenue Full definition →		4.76%	4.89%	5.02%	5.03%
Selling, General and Administrative Expense of Revenue Full definition →		43.66%	48.34%	50.75%	52.53%
Share Based Compensation of Revenue Full definition →		4.07%	4.69%	5.14%	5.38%
Operating CF/Net income Full definition →		1.05	0.78	0.24	0.37
Depreciation/Fixed assets Full definition →		0.52	0.59	0.68	0.78
Capex/Depreciation Full definition →		(0.34)	(0.37)	6.22	5.66
Revenue per Share Full definition →		1.56	1.63	1.63	1.63
Operating CF per Share Full definition →		0.27	0.17	0.06	0.08
Capex per Share Full definition →		0.00	0.00	0.07	0.07
Capex to Sales Full definition →		0.00	0.00	(0.04)	(0.04)

Show all line items

Columns are period end dates

Stockrow Weekly